Antibody immunotherapy is a well-established therapeutic modality for cancer, acute viral infections （Marasco and Sui, 2007） and persistent viral infection such as HIV （Barouch et al., 2013） and HCMV （Freed et al...Antibody immunotherapy is a well-established therapeutic modality for cancer, acute viral infections （Marasco and Sui, 2007） and persistent viral infection such as HIV （Barouch et al., 2013） and HCMV （Freed et al., 2013）. To reduce immunogenicity of rodent antibodies （Abs）, approved anti-body drugs entering clinical trials are of human origin or are humanized versions of rodent antibodies （Reichert, 2008）.展开更多
文摘Antibody immunotherapy is a well-established therapeutic modality for cancer, acute viral infections （Marasco and Sui, 2007） and persistent viral infection such as HIV （Barouch et al., 2013） and HCMV （Freed et al., 2013）. To reduce immunogenicity of rodent antibodies （Abs）, approved anti-body drugs entering clinical trials are of human origin or are humanized versions of rodent antibodies （Reichert, 2008）.
